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by Elsevier B.V. This is an open accesAbstract Inflammatory pseudo tumor (IPT) is a rare benign lesion that can occur in any organ
in the body. IPT is histologically characterized by the presence of inflammatory cells, espe-
cially, plasma cells, spindle-shaped cells, and myofibroblasts.
Many cases of IPTs affecting multiple organs in both adults and children have been docu-
mented in the literature. Fifty-five cases of hepatic IPTs have been reported in children,
and all of them were managed by surgical resection. Limited data are available on IPTs in
Arabs.
Our aim was to report the case of an 8-year-old Saudi boy who was referred to our hospital
with fever of unknown origin since 3 months with associated weight loss and a hepatic mass,
and was found to have an IPT of the liver, which was confirmed after surgical resection.
8 years old Saudi boy who presented with fever and liver mass. Ultrasound and MRI
abdomen showed heterogeneous liver mass. After surgical resection, his mass histology going
with inflammatory pseudo tumor. Following surgical resection his fever subsided.
The findings of the present case report show that fever and liver mass in children can be
manifestations of a rare disease such as IPT, which should be considered in the differential
diagnosis when all investigations are inconclusive. Based on the literature review, surgical
excision seems to be the best treatment strategy for this condition. However, the imaging
findings, especially the size and location of the mass, must be carefully discussed with the
surgical team before the operation.
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80 F. Alrwuili1. Introduction
Inflammatory pseudo tumor (IPT) is a rare benign lesion that
can occur in any organ in the body [1]. IPT is histologically
characterized by the presence of inflammatory cells, espe-
cially, plasma cells, spindle-shaped cells, and myofibro-
blasts. The exact etiology is unknown, but in some cases,
IPT has arisen after trauma, infection, immune-autoimmune
condition, low grade fibro sarcoma with inflammatory sur-
gery or the removal of a malignancy, e.g., Wilms tumor
[2,3]. Although IPT is a rare benign tumor, cases of IPT
recurrence and metastasis have been reported. In addition,
this tumor can cause symptoms such as biliary obstruction,
portal hypertension, vascular thrombosis, cirrhosis, and
hepatic failure. IPT most commonly involving the lung and
orbit, but it can affect any organ, including the liver, spleen
and lymph nodes. The diagnosis is difficult owing to the non-
specific clinical, laboratory and imaging features [4].
Many cases of IPTs affecting multiple organs in both
adults and children have been documented in the litera-
ture. Fifty-five cases of hepatic IPTs have been reported in
children [4,5], and all of them were managed by surgical
resection. Limited data are available on IPTs in Arabs. In
Saudi Arabia, a few cases have been reported of IPTs in
adults, involving the orbit and lungs, and occurring
following hip replacement surgery with metal-on-metal
implants [6,7]. To our knowledge, no cases of hepatic IPTs
in Saudi children have been documented.
Our aim was to report the case of an 8-year-old Saudi
boy who was referred to our hospital with fever of unknown
origin since 3 months with associated weight loss and a
hepatic mass. He was found to have an IPT of the liver
which was found after surgical resection.
2. History and physical examination
An 8-year-old Saudi boy who was previously healthy pre-
sented to a local Saudi hospital in June 2014 with right hip
joint pain and difficulty in walking. Hip joint aspiration was
performed, and the results were inconclusive. He was
treated for septic arthritis with a full course of intravenous
antibiotics. His condition improved with this treatment,
and he was then sent home. A few days after discharge, he
started to have daily spikes of fever, which reached 39 C
and only partially responded to antipyretics. He had no
other clinical symptoms at this time. He was again admitted
to a local hospital for 6 weeks. A physical examination
revealed a palpable, tender liver, 4e5 cm below the costal
margin, with no other abnormal findings. During his hospital
stay, several laboratory investigations were performed to
rule out infectious and inflammatory conditions, but all of
them yielded inconclusive results. He was empirically
treated with antibiotics, without any change in the fever
spikes. Radiological studies, including chest x-ray, were
normal. An ultrasound examination revealed a non-
homogenous liver mass measuring 4  4 cm, which was
possibly a solid or vascular tumor. The child was then
referred to King Faisal Specialist Hospital and Research
Centre, Riyadh for further evaluation and management.
Upon admission, he continued to be febrile (range,
38Ce39 C) with no specific pattern of fever. His appetitewas poor, and he was losing weight. A clinical examination
showed that the child was pale and had tenderness in the
upper right quadrant of the abdomen. No other abnormal
findings were detected.
3. Laboratory investigations
Laboratory investigations showed leukocytosis with micro-
cytic hypochromic anemia. Raised levels of inflammatory
markers (C-reactive protein, 170e240 mg/l; erythrocyte
sedimentation rate, 106e140 mm/h). Liver enzymes and
bilirubin levels were mildly elevated (alanine transaminase,
40e58 U/l; alkaline phosphatase, 129e250 U/l; aspartate
transaminase, 50e144 U/l; gamma-glutamyl trans-
peptidase, 50e70 U/l; total bilirubin, 45e70 mmol/l; and
direct bilirubin, 15 mmol/l). Coagulation profiles showed
persistently high international normalized ratio (1.3e1.9
HI), prothrombin time (PT; 18e21 s), partial thromboplastin
time (PTT; 40e58 s), factor VIII (>2 IU/ml), factor IX (1.17
IU/ml) and D-dimer levels (110e165 mg/l), and coagulation
level was not corrected after mixing study (PT, 16 s; PTT,
50 s). Tests for infections also yielded negative results; the
work-up for infections included blood culture, fungi tell
(fungitell), fungal cultures, tests for ova and parasites,
tuberculosis skin test, quantiFERON TB test. Serologic tests
for hepatitis A, B and C, schist soma (Shistosoma) antibody
titers, malarial serology, Q fever serology, Echinococcus
antibody titers, Brucella antibody titers, EpsteineBarr virus
serology, cytomegalovirus antibodies, human immunodefi-
ciency virus antibodies and amoeba antibodies. Immuno-
logical work-up, to rule out chronic granulomatous disease,
hyper IgE and lymphocyte adhesion defect and hemopha-
gocytic syndrome, was negative. Inflammatory disease
work-up included tests for antinuclear, anti-cardiolipin and
anti-phospholipid antibodies, all of which were negative.
Tumor markers, including alpha-fetoprotein, CA 19-9, CA
15-3, CA 12-5, carcinoembryonic antigen and procalcitonin,
were tested for to rule out malignancy; all of these tests
produced normal results.
4. Radiological investigations
Radiological investigation was repeated to assess the tumor
size and confirm the primary findings. Ultrasonography of the
abdomen showed a well-defined, heterogenic mass,
measuring4 6cm, in the rightupperquadrantwithcomplete
thrombosis of the right hepatic vein (Fig. 1). The initial
impression was a vascular tumor or malignancy. For this
reason, magnetic resonance imaging was performed, and it
showed a heterogeneous solitary lesion in the right hepatic
lobe with nonspecific radiological appearance (Fig. 2).
Our patient underwent multiple ultrasound-guided core
and fine needle liver biopsies. The liver mass located in the
right lobe was aspirated using a 25-gauge needle and
stained with Diff-Quik stain. The aspirate showed a small
amount of cellular yield with benign liver cells mixed with
benign-looking histiocytes (Fig. 3A and B). The recommen-
dation was to perform a Tru-Cut needle biopsy for the
appropriate staining and immunohistochemical studies. The
Tru-Cut needle biopsy was obtained under imaging guid-
ance and tissues were sent for appropriate staining and
Figure 1 Ultrasoundexamination of theupper abdomen showingaheterogeneousmass,measuring4 6 cm, in the right hepatic lobe.
Figure 2 T2-weighted MRI of the abdomen showing a soli-
tary, moderate-sized, complex mass occupying the right lobe
of the liver. The differential diagnosis included liver malig-
nancy with extension to the right hepatic vein.
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of chronic inflammatory cells and sheets of histiocytes with
abundant cytoplasm. Acid-fast bacilli and fungal infection
were excluded by special stains. The biopsy showed no
obvious pathological or immunohistochemical features ofFigure 3 A and B. Smears containing a mixture of beniinflammatory myofibroblastic tumor (negative smooth
muscle actin and activin receptor-like kinase 1). The other
differential diagnosis was dendritic sarcoma, but the biopsy
specimen was negative for both CD21 and CD23. Inflam-
matory bowel disease was also raised as a possible diag-
nosis, and so, an endoscopic intestinal biopsy was
performed, but the findings were negative.
After a multidisciplinary team meeting and discussion
with a liver pathologist, the decision was made to perform
an excisional biopsy to obtain a better tissue sample for
diagnosis. Because of the size and location of the mass, the
excisional biopsy was performed by a liver transplant sur-
geon in August 2014. Under general anesthesia, an L-shaped
incision was made in the right subcostal region with an
upper midline extension, and a HampsoneFarley self-
retaining abdominal retractor was used to enter the
abdomen via this incision. Then, exploration of the
abdomen was performed, and no tumor extension or
metastasis was found in the omentum or peritoneum. The
lesion was confined to the right lobe of the liver, as previ-
ously seen on the imaging studies, and had a diameter of
approximately 5 cm. Therefore, transection of the hepatic
parenchyma of the right lobe of the liver, followed by
removal of the right hepatic lobe was performed. After the
removal of the mass, fever subsided, and antibiotic therapy
was stopped after completing the postoperative course.
The postoperative laboratory investigation, including com-
plete blood count, tests for inflammatory markers and
coagulation profile, showed normal findings. The patient
was then sent home, and regularly followed up by the
hepatology and liver transplant teams.gn hepatocytes and histiocytes (Diff-Quik stain, 40).
Figure 4 Cross-section of the mass is well demarcated and
has a whiteeyellow, fleshy cut surface.
Figure 5 The mass is separated from the surrounding tissue
by a thick fibrous capsule.
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The resected right lobe of the liver showed two lesions
separatedby 1.5 cm.The largestmassmeasured8 6 5 cm,
and had a white fleshy cut surface. Themass was surrounded
by a well-demarcated thin capsule (Figs. 4 and 5). Micro-
scopic examination showed similar morphology to that of the
needle biopsy specimen,with amixture of inflammatory cells
and sheets of histiocytic. The inflammatory cells mainly
consisted of plasma cells and mature lymphocytes, and were
largely concentrated in the sub capsular area and around the
bloodvessels (Figs. 6 and7A, B).Nogranulomaor necrosiswas
seen. All special stains and immunohistochemical studies
were repeated on the resected nodule, with mostly negative
results. The histiocytic were positive for the histiocytic
marker CD68 (Fig. 7A and B). The plasma cell infiltrate was
stained for IgG4, but the number of positively stained cells
was insufficient for a diagnosis of IgG4-related disease
(Fig. 8).
6. Discussion
A review of the literature revealed a few reports of IPTs in
patients belonging to different age groups. In most of the
reported cases, surgical resection was required to treat the
symptoms [1]. The recurrence rates of IPT are 3%e10% in
adults and 14% in children [8]. The risk factors for IPT
recurrence are irregularity of tumor margins, failure to
resect the whole tumor and extension beyond the involved
organ or the involvement of many organs [8]. Hepatic
tumors are rare, affecting men more than women. They
mostly present with fever and abdominal pain. In litera-
ture, review most of the cases are treated by resection [9].
In our patient, fever was completely resolved following
tumor resection. The inflammatory marker levels returned
to normal in a couple of months, and the patient was fol-
lowed up by the liver transplant and hepatology teams.
Before the right hepatic lobectomy, the hepatology
team recommended a liver biopsy of the normal liver tissue
to rule out any systemic illness that could have caused
recurrence. This precaution was very important in our pa-
tient, given the large size of the tissue to be removed.The patient may require a liver transplant in the future, if
systemic disease had been present. The tumor was large,
measuring around 5  5 cm, occupying most of the right
hepatic lobe and causing vascular compression. This is why
the best treatment option was resection.
Our patient had a prolonged PT (range and unit) and
elevated factor VIII level (range and unit), which were most
likely a result of liver dysfunction. Liver biopsy is an inva-
sive procedure that can be complicated with life-
threatening bleeding [10], which was a distinct possibility
in our patient. Therefore, we administered fresh frozen
plasma and factor VII prior to the biopsy and total excision
of the mass.
Factor VII can be used as an exogenous source to
augment the coagulation cascade [11]. There are limited
data on the use of factor VII in liver disease-related coag-
ulation dysfunction, and many doses have been reported in
the literature. In one study, four different doses (5, 20, 80,
and 120 mg/kg) were used in patients with liver cirrhosis
prior to laparoscopic liver biopsy, and transient normali-
zation of PT was achieved in all four groups [12]. There was
no difference in the amount of hepatic bleeding after the
procedure in the four groups, and only two patients
developed complications (disseminated intravascular
coagulation in one patient and portal vein thrombosis in the
other). The authors mentioned that these complications
were not directly related to the use of factor VII [13]. We
recommend that patients with hepatic vein thrombosis who
require major surgery should not be administered high
doses of recombinant activated factor VII, as this can
induce further thrombosis (14).
The findings of the present case report show that fever
and liver mass in children can be manifestations of a rare
disease such as IPT, which should be considered in the
differential diagnosis when all investigations are inconclu-
sive. Based on the literature review, surgical excision seems
to be the best treatment strategy for this condition. How-
ever, the imaging findings, especially the size and location
of the mass, must be carefully discussed with the surgical
team before the operation. Further studies are required to
determine the safest dose of recombinant activated factor
FVII in patients with liver disease-related coagulopathy.
Figure 7 A and B. All the histiocytes in the tissue specimen are positive for CD68 (hematoxylin and eosin, CD68; 40).
Figure 8 A few plasma cells are positive for IgG4 (IgG4,40).
Figure 6 A and B. Lymphoplasmocytic cell infiltration is concentrated in the subcapscular area and around the blood vessels
(hematoxylin and eosin, 40).
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